Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease

Journal of Gastrointestinal and Liver Diseases

Volumn 23, Issue 2, 2014, Pages 127-133

  Gross, Sascha ^a   Bakker, Sjoerd F ^a   van Bodegraven, Adriaan A ^a   van Hoogstraten, Ingrid M W ^a   Gelderman, Kyra A ^a   Bouma, Gerd ^a   Mulder, Chris J ^a   von Blomberg, B Mary E ^a   Bontkes, Hetty J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Celiac disease; Crohn's disease; Glycoprotein 2 antibodies; Refractory celiac disease; Ulcerative colitis

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; AUTOANTIBODY; BIOLOGICAL MARKER; BOVINE SERUM ALBUMIN; FUNGUS ANTIBODY; GLYCOPROTEIN-2, PANCREAS; IMMUNOGLOBULIN G; MEMBRANE PROTEIN;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; DIET THERAPY; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY; PROGNOSIS; TREATMENT FAILURE;

ADULT; AGED; ANTIBODIES, FUNGAL; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; COLITIS, ULCERATIVE; CROHN DISEASE; DIET, GLUTEN-FREE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; SACCHAROMYCES CEREVISIAE; SERUM ALBUMIN, BOVINE; TREATMENT FAILURE;

EID: 84901940680     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:413-424.
2. Verbeek WH, Schreurs MW, Visser OJ, von Blomberg BM, Al-Toma A, Mulder CJ. Novel approaches in the management of refractory celiac disease. Expert Rev Clin Immunol 2008;4:205-219.
3. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007;147:294-302.
4. Roggenbuck D, Reinhold D, Wex T, et al. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta 2011;412:718-724.
5. Op De Beeck K, Vermeire S, Rutgeerts P, Bossuyt X. Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases. Gut 2012;61:162-164.
6. Pavlidis P, Forbes A, Bogdanos DP. Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK. Clin Chim Acta 2011;412:1163-1164.
7. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009;58:1620-1628.
8. Bogdanos DP, Roggenbuck D, Reinhold D, et al. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. BMC Gastroenterol 2012;12:102.
9. Bonaci-Nikolic B, Spuran M, Andrejevic S, Nikolic M. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sensitive enteropathy: a possible serological trap. Clin Chim Acta 2012;413:822-823.
10. Gross S, van Wanrooij RL, Tack GJ, et al. Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease. Eur J Gastroenterol Hepatol 2013;25:516-518.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
12. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
13. de Vries M, van der Horst-Bruinsma I, van Hoogstraten I, et al. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease. J Rheumatol 2010;37:2340-2344.
14. Verbeek WH, Goerres MS, von Blomberg BM, et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clin Immunol 2008;126:48-56.
15. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-1194.
16. United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 2001;13:1123-1128.
17. Pavlidis P, Romanidou O, Roggenbuck D, et al. Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease. Clin Dev Immunol 2012;2012:640835.
18. Roggenbuck D, Reinhold D, Schierack P, Bogdanos DP, Conrad K, Laass MW. Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges. Clin Chem Lab Med 2014;52:482-494.
19. Granito A, Muratori P, Cassani F, et al. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol 2004;137:386-392.
20. Mallant-Hent RC, Mary B, von Blomberg E, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 2006;18:75-78.
21. Damoiseaux JG, Bouten B, Linders AM, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002;22:281-288.
22. Granito A, Zauli D, Muratori P, et al. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther 2005;21:881-887.
23. Hase K, Kawano K, Nochi T, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009;462:226-230.
24. Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 2012;61:1355-1364.